SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filings

Filing date Form Description Filing Group View
FWP

FWP

Other
View HTML
FWP

FWP

Other
View HTML
FWP

FWP

Other
View HTML
FWP

FWP

Other
View HTML
FWP

FWP

Other
View HTML
IRANNOTICE

Notice of disclosure filed in Exchange Act quarterly and annual reports pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act

Other
View HTML
NO ACT

NO ACT

Other
View HTML
NO ACT

NO ACT

Other
View HTML
NO ACT

NO ACT

Other
View HTML
NO ACT

NO ACT

Other
View HTML

Data provided by Kaleidoscope.